Additional treatment in the congestive states of the upper airways.

RESERVED FOR ADULTS AND CHILDREN OVER 12 YEARS

Inhalation by fumigation. DO NOT: AVALER.

Dilute 50 drops in a container with hot water and inhale the vapors. Repeat the inhalations 3 times a day.

DISCONTINUED

(R.; Respiratory system)

This drug contains derivatives, terpene that can lower the threshold, epileptogenic.


· Hypersensitivity to the product

· Contra-indication due to the presence of terpenic derivatives: child with a history of convulsions (febrile or not)

Special warnings

This medicinal product contains propylene glycol and may cause skin irritation

· Do not swallow

· In case of allergic reaction, suspend treatment.

In case of persisting symptoms and / or signs of superinfection,
Re-evaluate therapeutic behavior.

This specialty contains terpene derivatives which can lead to excessive doses

· Seizure-type accidents, infants and children

· Respiratory breaks and collapse in the infant

Observe the advice of use and dosage, in particular, never exceed the recommended doses.

It is recommended not to use Aromasol in an enclosed space.

AROMASOL is not recommended during pregnancy and in women of childbearing age who do not use contraception (see section on Pregnancy and lactation). >
Precautions for use

In case of antecedent epilepsy, take into account the presence of terpene derivatives.

Due to the presence of terpene derivatives

Association to be taken into account

+ Other drugs lowering the epileptogenic threshold

Increased risk of convulsions

Pregnancy

AROMASOL contains terpene derivatives. There is little or no data for the use of terpenic derivatives in pregnant women. AROMASOL is not recommended during pregnancy and in women of childbearing age who do not use contraception.


In the absence of sufficient information on the passage of terpenic derivatives in breast milk and their potential neurological toxicity, this medication should not be used in infants if breast-feeding is used. >

Possibility of local irritation, allergy.

Due to the presence of derivatives, terpenic and in case of non-respect of the doses, recommended

· Risk of convulsions in infants and children

· Possibility of agitation and confusion in the elderly

Reporting of suspected adverse reactions

The reporting of suspected adverse effects after authorization of the drug is important. It provides continuous monitoring of the benefit / risk ratio of the drug. Health professionals report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and Network of Regional Centers, Pharmacovigilance -
Additional treatment in the congestive states of the upper airways.